Evidence Repository
The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • See Evidence submitted by expert panel for details.

Variant: NM_130838.1(UBE3A):c.1745_1747delCTT (p.Ser582del)

CA333369

155987 (ClinVar)

Gene: UBE3A
Condition: Angelman syndrome
Inheritance Mode: Autosomal dominant inheritance (with paternal imprinting (HP:0012274))
Link to MONDO
UUID: 63c4c18c-b6ad-4d46-90d9-5ab500c96c58
Approved on: 2021-03-26
Published on: 2021-05-17

HGVS expressions

NM_130838.1:c.1745_1747del
NM_130838.1:c.1745_1747delCTT
NM_130838.1(UBE3A):c.1745_1747delCTT (p.Ser582del)
ENST00000438097.6:c.1745_1747del
ENST00000625778.3:c.1745_1747del
ENST00000635914.1:c.1745_1747del
ENST00000637886.1:c.1805_1807del
ENST00000638011.1:c.1745_1747del
ENST00000638155.1:c.1745_1747del
ENST00000648336.2:c.1805_1807del
ENST00000649550.1:c.1745_1747del
ENST00000650110.1:c.1814_1816del
ENST00000675177.1:c.1628_1630del
ENST00000675593.1:n.4501_4503del
ENST00000232165.7:c.1745_1747del
ENST00000397954.6:c.1814_1816del
ENST00000428984.6:c.1745_1747del
ENST00000438097.5:c.1745_1747del
ENST00000566215.5:c.1745_1747del
ENST00000614096.4:c.1805_1807del
ENST00000625778.2:c.1745_1747del
ENST00000630424.2:c.1745_1747del
ENST00000631247.1:n.294_296del
NM_000462.3:c.1814_1816del
NM_130839.2:c.1805_1807del
NM_000462.5:c.1814_1816del
NM_001354505.1:c.1805_1807del
NM_001354506.1:c.1745_1747del
NM_001354507.1:c.1745_1747del
NM_001354508.1:c.1745_1747del
NM_001354509.1:c.1745_1747del
NM_001354511.1:c.1745_1747del
NM_001354512.1:c.1745_1747del
NM_001354513.1:c.1745_1747del
NM_001354523.1:c.1745_1747del
NM_001354526.1:c.1745_1747del
NM_001354538.1:c.1805_1807del
NM_001354539.1:c.1745_1747del
NM_001354540.1:c.1745_1747del
NM_001354541.1:c.1745_1747del
NM_001354542.1:c.1745_1747del
NM_001354543.1:c.1745_1747del
NM_001354544.1:c.1745_1747del
NM_001354545.1:c.1805_1807del
NM_001354546.1:c.1628_1630del
NM_001354547.1:c.1745_1747del
NM_001354548.1:c.1745_1747del
NM_001354549.1:c.1745_1747del
NM_001354550.1:c.554_556del
NM_001354551.1:c.494_496del
NM_130838.3:c.1745_1747del
NM_130839.4:c.1805_1807del
NR_146177.1:n.18393-34749_18393-34747del
NR_148916.1:n.2349_2351del
NM_001354506.2:c.1745_1747del
NM_001354507.2:c.1745_1747del
NM_001354508.2:c.1745_1747del
NM_001354509.2:c.1745_1747del
NM_001354511.2:c.1745_1747del
NM_001354512.2:c.1745_1747del
NM_001354513.2:c.1745_1747del
NM_001354523.2:c.1745_1747del
NM_001354538.2:c.1805_1807del
NM_001354539.2:c.1745_1747del
NM_001354540.2:c.1745_1747del
NM_001354541.2:c.1745_1747del
NM_001354542.2:c.1745_1747del
NM_001354543.2:c.1745_1747del
NM_001354544.2:c.1745_1747del
NM_001354545.2:c.1805_1807del
NM_001354546.2:c.1628_1630del
NM_001354547.2:c.1745_1747del
NM_001354548.2:c.1745_1747del
NM_001354549.2:c.1745_1747del
NM_001354550.2:c.554_556del
NM_001354551.2:c.494_496del
NM_001374461.1:c.1745_1747del
NM_130838.4:c.1745_1747del
NM_130839.5:c.1805_1807del
NR_148916.2:n.2317_2319del
NC_000015.10:g.25356847_25356849del
CM000677.2:g.25356847_25356849del
NC_000015.9:g.25601994_25601996del
CM000677.1:g.25601994_25601996del
NC_000015.8:g.23153087_23153089del
NG_009268.1:g.87137_87139del
More

Likely Pathogenic

Met criteria codes 4
PP4 PM6_Strong PM2_Supporting PS4_Supporting

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The p.Ser582del variant in UBE3A is absent from gnomAD (PM2_Supporting). The p.Ser582del variant in UBE3A has been reported in at least 2 de novo occurrences (biological parentage unconfirmed) in individuals with Angelman syndrome (PMID 25212744, internal database) (PM6_Strong). The p.Ser582del variant has been observed in at least 1 other individual with Angelman syndrome (PMID 25212744) (PS4_Supporting). The p.Ser582del variant in UBE3A has been reported in an individual with a clinical phenotype suggestive of Angelman syndrome (PMID 25212744) (PP4). In summary, the p.Ser582del variant in UBE3A is classified as likely pathogenic for Angelman syndrome based on the ACMG/AMP criteria (PM2_supporting, PM6_strong, PS4_supporting, PP4).
Met criteria codes
PP4
The p.Ser582del variant in UBE3A has been reported in an individual with a clinical phenotype suggestive of Angelman syndrome (PMID 25212744)
PM6_Strong
The p.Ser582del variant in UBE3A has been reported in at least 2 de novo occurrences (biological parentage unconfirmed) in individuals with Angelman syndrome (PMID 25212744, internal database)
Review of UBE3A variants identified in a cohort of 2515 AS patients. Variant identified in 1 patient, found to be de novo PubMed:25212744
PM2_Supporting
The p.Ser582del variant in UBE3A is absent from gnomAD
PS4_Supporting
The p.Ser582del variant has been observed in at least 1 other individual with Angelman syndrome (PMID 25212744)
Review of UBE3A variants identified in a cohort of 2515 AS patients. Variant identified in 1 patient, found to be de novo PubMed:25212744
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.